These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9672527)

  • 1. Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates.
    Farnoux C; Camard O; Pinquier D; Hurtaud-Roux MF; Sebag G; Schlegel N; Beaufils F
    J Pediatr; 1998 Jul; 133(1):137-40. PubMed ID: 9672527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of neonatal arterial thromboses with recombinant tissue plasminogen activator.
    Weiner GM; Castle VP; DiPietro MA; Faix RG
    J Pediatr; 1998 Jul; 133(1):133-6. PubMed ID: 9672526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolysis of mechanical prosthetic valve thrombosis: a single-center study of 127 cases.
    Roudaut R; Lafitte S; Roudaut MF; Courtault C; Perron JM; Jaïs C; Pillois X; Coste P; DeMaria A
    J Am Coll Cardiol; 2003 Feb; 41(4):653-8. PubMed ID: 12598078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Tissue Plasminogen Activator in the Treatment of Neonates with Intracardiac and Great Vessels Thrombosis.
    El-Segaier M; Khan MA; Khan ZU; Momenah T; Galal MO
    Pediatr Cardiol; 2015 Dec; 36(8):1582-7. PubMed ID: 25991571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant tissue plasminogen activator.
    Bell SG
    Neonatal Netw; 1996 Sep; 15(6):13-8. PubMed ID: 8932068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spontaneous neonatal arterial thrombosis treated with tissue plasminogen activator].
    Daoud P; Quetin P; Saillant A; Rousset A; Castaing H
    Arch Pediatr; 1997 Apr; 4(4):343-6. PubMed ID: 9183407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators.
    Bode C; Smalling RW; Berg G; Burnett C; Lorch G; Kalbfleisch JM; Chernoff R; Christie LG; Feldman RL; Seals AA; Weaver WD
    Circulation; 1996 Sep; 94(5):891-8. PubMed ID: 8790022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolytic therapy.
    Collen D; Lijnen HR
    Ann N Y Acad Sci; 1991; 614():259-69. PubMed ID: 1902640
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of neonatal thrombus formation with recombinant tissue plasminogen activator: six years experience and review of the literature.
    Hartmann J; Hussein A; Trowitzsch E; Becker J; Hennecke KH
    Arch Dis Child Fetal Neonatal Ed; 2001 Jul; 85(1):F18-22. PubMed ID: 11420316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful use of recombinant tissue plasminogen activator in the treatment of aortic thrombosis in a premature neonate.
    Torkington J; Hitchcock R; Wilkinson K; Kiely E
    Eur J Vasc Endovasc Surg; 1997 May; 13(5):515-6. PubMed ID: 9166277
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biochemical, pharmacologic and clinical properties of new thrombolytic agents].
    Gulba DC
    Internist (Berl); 1996 Jun; 37(6):552-66. PubMed ID: 8767988
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination thrombolytic and anticoagulant therapy for bilateral renal vein thrombosis in a premature infant.
    Weinschenk N; Pelidis M; Fiascone J
    Am J Perinatol; 2001 Aug; 18(5):293-7. PubMed ID: 11552182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serine-proteases as plasminogen activators in terms of fibrinolysis.
    Flemmig M; Melzig MF
    J Pharm Pharmacol; 2012 Aug; 64(8):1025-39. PubMed ID: 22775207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of plasminogen activators in the treatment of deep venous thrombosis].
    Bollaert PE
    Ann Cardiol Angeiol (Paris); 2002 Jun; 51(3):169-71. PubMed ID: 12471649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of a catheter-related right atrial thrombosis with recombinant tissue plasminogen activator and heparin.
    Cesaro S; Paris M; Corrò R; Svaluto G; Zanon GF; Gamba P; Milanesi O; Messina C; Zanesco L
    Support Care Cancer; 2002 Apr; 10(3):253-5. PubMed ID: 11904791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary artery thrombus in a premature neonate treated with recombinant tissue plasminogen activator.
    DeMeo SD; Sherwood A; Hornik CD; Goldberg RN; Cotten CM; Bidegain M
    J Perinatol; 2014 Jul; 34(7):569-71. PubMed ID: 24968902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolytic therapy in children--clinical experiences with recombinant tissue-plasminogen activator.
    Knöfler R; Dinger J; Kabus M; Müller D; Lauterbach I; Rupprecht E; Taut-Sack H; Weissbach G
    Semin Thromb Hemost; 2001; 27(2):169-74. PubMed ID: 11372772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Subtotal thrombosis of the juxta-ductal thoracic aorta in a premature 36-week-old infant. Alteplase therapy].
    Di Bernardo S; Sekarski N; Tolsa JF; Lavanchy L; Payot M
    Arch Mal Coeur Vaiss; 1999 May; 92(5):661-5. PubMed ID: 10367084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recombinant tissue plasminogen activator for the management of intracardiac thrombi in newborns].
    Álvarez Z P; Verdugo L P; Carvajal K L; Múhlhausen M G; Ríos A P; Rodríguez V D
    Rev Chil Pediatr; 2015; 86(3):194-9. PubMed ID: 26235268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.